Everlife Group is one of Asia's leading and most trusted market access and distribution platforms for medical devices and laboratory equipment and supplies. By combining technology with our expertise in healthcare, Asia and a passionate and results-driven approach to business, we aim to improve health outcomes for patients and improve business performance for customers and principals. Everlife companies represent over 200 principals and a team of 800 employees that operate across 6 countries. Everlife is part of the Everstone Group and Cure Capital is a minority investor. To learn more, visit www.everlifeasia.com or visit us on Linkedin.
Location: Singapore
Employees: 501-1000
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | HBM Partne... | hbmpartner... |
Mentions in press and media 4
| Date | Title | Description |
| 10.03.2022 | Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia | SINGAPORE, March 10, 2022 /PRNewswire/ -- Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Research Instrumen... |
| 13.10.2021 | AUM Biosciences announces closing of USD $27Million in a "Series A" Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies | SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the successful completion of USD $27 million series A funding round. This will fuel AUM's vision of developing a world class biotech pipeline focused on drugging... |
| 12.10.2021 | AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies | SINGAPORE and NEW YORK, October 12, 2021 – AUM Biosciences (AUM) today announced the successful completion of $27 million series A funding round. This will fuel AUM’s vision of developing a world class biotech pipeline focused on drugging w... |
| 02.07.2021 | Ramesh Subrahmanian joins Everlife Board | SINGAPORE and MUMBAI, India, July 2, 2021 /PRNewswire/ -- Everlife Holdings Pte. Ltd. ("Everlife"), a leading manufacturer and distributor of medical devices and laboratory equipment and consumables in Asia, has appointed Ramesh S... |